HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yang Yang Selected Research

norcholic acid

1/2021Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yang Yang Research Topics

Disease

976Neoplasms (Cancer)
12/2022 - 09/2001
191Inflammation (Inflammations)
12/2022 - 06/2006
187Neoplasm Metastasis (Metastasis)
12/2022 - 12/2003
183Infections
12/2022 - 04/2002
121Hepatocellular Carcinoma (Hepatoma)
09/2022 - 04/2002
110Carcinogenesis
07/2022 - 04/2003
80Breast Neoplasms (Breast Cancer)
08/2022 - 10/2004
75Lung Neoplasms (Lung Cancer)
11/2022 - 02/2004
72Stomach Neoplasms (Stomach Cancer)
10/2022 - 12/2008
66Reperfusion Injury
12/2022 - 02/2002
64COVID-19
05/2022 - 01/2020
61Fibrosis (Cirrhosis)
09/2022 - 09/2008
61Pain (Aches)
07/2022 - 01/2011
61Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 01/2009
60Glioma (Gliomas)
04/2022 - 04/2008
59Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 02/2004
51Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2010
44Carcinoma (Carcinomatosis)
01/2022 - 11/2006
42Myocardial Ischemia (Ischemic Heart Diseases)
12/2022 - 08/2005
42Prostatic Neoplasms (Prostate Cancer)
10/2022 - 11/2003
42Hypoxia (Hypoxemia)
02/2022 - 07/2006
39Wounds and Injuries (Trauma)
06/2022 - 01/2011
38Ischemia
01/2022 - 08/2009
36Sepsis (Septicemia)
10/2022 - 12/2003
36Adenocarcinoma of Lung
06/2022 - 07/2010
35Multiple Myeloma
01/2022 - 12/2003
32Obesity
08/2022 - 06/2009
32Esophageal Squamous Cell Carcinoma
05/2022 - 03/2011
32Leukemia
01/2021 - 09/2003
31Stroke (Strokes)
11/2022 - 02/2007
30Body Weight (Weight, Body)
08/2022 - 03/2011
29Liver Neoplasms (Liver Cancer)
01/2022 - 10/2014
28Myocardial Infarction
12/2022 - 12/2010
28Colonic Neoplasms (Colon Cancer)
09/2022 - 09/2007
28Mitochondrial Diseases (Mitochondrial Disease)
06/2022 - 02/2009
28Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2009
27Cardiovascular Diseases (Cardiovascular Disease)
06/2022 - 02/2012
27Cognitive Dysfunction
02/2022 - 06/2012
27Type 2 Diabetes Mellitus (MODY)
01/2022 - 06/2009
26Esophageal Neoplasms (Esophageal Cancer)
11/2022 - 03/2011
26Neurodegenerative Diseases (Neurodegenerative Disease)
02/2022 - 05/2012
25Melanoma (Melanoma, Malignant)
04/2022 - 06/2010
25Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 06/2009
24Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 05/2008
24Hypertension (High Blood Pressure)
01/2021 - 01/2008
24Infarction (Infarctions)
01/2021 - 12/2008
23Liver Cirrhosis (Hepatic Cirrhosis)
05/2022 - 04/2002
22Hemorrhage
09/2022 - 01/2007
22Ischemic Stroke
01/2022 - 01/2015
22Atherosclerosis
12/2021 - 04/2012
21Insulin Resistance
09/2022 - 01/2007
21Necrosis
05/2022 - 12/2008

Drug/Important Bio-Agent (IBA)

320Proteins (Proteins, Gene)FDA Link
09/2022 - 02/2002
200Pharmaceutical PreparationsIBA
07/2022 - 09/2001
144Biomarkers (Surrogate Marker)IBA
10/2022 - 09/2008
128MicroRNAs (MicroRNA)IBA
12/2022 - 04/2010
98Biological ProductsIBA
09/2022 - 11/2008
93CytokinesIBA
09/2022 - 12/2003
80Long Noncoding RNAIBA
12/2022 - 01/2014
76Messenger RNA (mRNA)IBA
09/2022 - 01/2006
65DNA (Deoxyribonucleic Acid)IBA
10/2022 - 10/2004
62Small Interfering RNA (siRNA)IBA
06/2022 - 08/2008
60Therapeutic UsesIBA
07/2022 - 05/2008
60RNA (Ribonucleic Acid)IBA
04/2022 - 04/2008
58Peptides (Polypeptides)IBA
12/2022 - 04/2010
56EnzymesIBA
10/2022 - 12/2003
49Glucose (Dextrose)FDA LinkGeneric
10/2022 - 04/2007
48LipidsIBA
12/2022 - 01/2007
48CateninsIBA
01/2022 - 12/2010
44VaccinesIBA
03/2022 - 04/2004
43Interleukin-6 (Interleukin 6)IBA
01/2022 - 12/2008
42Liposomes (Liposome)IBA
12/2022 - 01/2009
42Antiviral Agents (Antivirals)IBA
12/2022 - 04/2004
42AntigensIBA
10/2022 - 10/2005
39Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2022 - 08/2005
37Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2010
36Phosphotransferases (Kinase)IBA
04/2022 - 07/2005
36LigandsIBA
01/2022 - 08/2008
33Indicators and Reagents (Reagents)IBA
07/2022 - 04/2007
33MelatoninIBA
12/2021 - 09/2013
32Transcription Factors (Transcription Factor)IBA
01/2022 - 08/2006
31LipopolysaccharidesIBA
10/2022 - 12/2003
31Circular RNAIBA
09/2022 - 01/2017
29Cisplatin (Platino)FDA LinkGeneric
09/2022 - 03/2011
27Doxorubicin (Adriamycin)FDA LinkGeneric
07/2022 - 04/2012
27Caspase 3 (Caspase-3)IBA
06/2022 - 10/2004
26Sirtuin 1IBA
07/2022 - 09/2013
25AntioxidantsIBA
05/2022 - 01/2009
24InterferonsIBA
12/2022 - 01/2013
23ErbB Receptors (EGF Receptor)IBA
10/2022 - 06/2008
22AntibodiesIBA
01/2022 - 05/2011
21InflammasomesIBA
09/2022 - 07/2012

Therapy/Procedure

403Therapeutics
12/2022 - 03/2002
131Drug Therapy (Chemotherapy)
11/2022 - 09/2004
73Liver Transplantation
12/2022 - 03/2002
55Immunotherapy
11/2022 - 03/2010
32Radiotherapy
04/2022 - 01/2015
26Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 01/2007
26Transplantation
06/2022 - 03/2002
25Length of Stay
07/2022 - 10/2009